Clinical • Checkpoint inhibition • PD(L)-1 Biomarker • IO biomarker • Metastases
|
FASLG (Fas ligand) • ICOS (Inducible T Cell Costimulator) • ICOSLG (Inducible T Cell Costimulator Ligand) • FAS (Fas cell surface death receptor)
|
ICOSLG overexpression • FAS overexpression • FASLG overexpression + ICOSLG overexpression
|
Keytruda (pembrolizumab)